Literature DB >> 26321650

Permutations of time and place in tuberculosis.

Paul T Elkington1, Jon S Friedland2.   

Abstract

Tuberculosis remains a global health pandemic. The current depiction of the Mycobacterium tuberculosis life cycle proposes that airborne bacilli are inhaled and phagocytosed by alveolar macrophages, resulting in the formation of a granuloma that ruptures into the airways to reinitiate the infectious cycle. However, this widely proposed model overlooks the fact, established 100 years ago, that the initial site of M tuberculosis implantation is in the lower zones of the lungs, whereas infectious cavitary pulmonary disease develops at the lung apices. The immunological events at these two pulmonary locations are different--cavitation only occurs in the apices and not in the bases. Yet the current conceptual model of tuberculosis renders the immunology of these two temporally and spatially separated events identical. One key consequence is that prevention of primary childhood tuberculosis at the lung bases is regarded as adequate immunological protection, but extensive evidence shows that greater immunity could predispose to immunopathology and transmission at the lung apex. A much greater understanding of time and place in the immunopathological mechanisms underlying human tuberculosis is needed before further pre-exposure vaccination trials can be done.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321650      PMCID: PMC4872044          DOI: 10.1016/S1473-3099(15)00135-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  44 in total

1.  Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation.

Authors:  Joe Swift; Irena L Ivanovska; Amnon Buxboim; Takamasa Harada; P C Dave P Dingal; Joel Pinter; J David Pajerowski; Kyle R Spinler; Jae-Won Shin; Manorama Tewari; Florian Rehfeldt; David W Speicher; Dennis E Discher
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

2.  Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics.

Authors:  Reza Yaesoubi; Ted Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

3.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

Authors:  Seok-Yong Eum; Ji-Hye Kong; Min-Sun Hong; Ye-Jin Lee; Jin-Hee Kim; Soo-Hee Hwang; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

4.  Apical localization of phthisis; its significance in treatment by prolonged rest in bed.

Authors:  W DOCK
Journal:  Am Rev Tuberc       Date:  1946-04

5.  Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide.

Authors:  Y Yamamura; Y Ogawa; H Maeda; Y Yamamura
Journal:  Am Rev Respir Dis       Date:  1974-06

6.  Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.

Authors:  André Kübler; Brian Luna; Christer Larsson; Nicole C Ammerman; Bruno B Andrade; Marlene Orandle; Kevin W Bock; Ziyue Xu; Ulas Bagci; Daniel J Mollura; John Marshall; Jay Burns; Kathryn Winglee; Bintou Ahmadou Ahidjo; Laurene S Cheung; Mariah Klunk; Sanjay K Jain; Nathella Pavan Kumar; Subash Babu; Alan Sher; Jon S Friedland; Paul T G Elkington; William R Bishai
Journal:  J Pathol       Date:  2014-10-06       Impact factor: 7.996

Review 7.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

8.  Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.

Authors:  Naomi F Walker; Simon O Clark; Tolu Oni; Nuria Andreu; Liku Tezera; Shivani Singh; Luísa Saraiva; Bernadette Pedersen; Dominic L Kelly; Julia A Tree; Jeanine M D'Armiento; Graeme Meintjes; Francesco A Mauri; Ann Williams; Robert J Wilkinson; Jon S Friedland; Paul T Elkington
Journal:  Am J Respir Crit Care Med       Date:  2012-02-16       Impact factor: 21.405

9.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

Authors:  Paul Elkington; Takayuki Shiomi; Ronan Breen; Robert K Nuttall; Cesar Augusto Ugarte-Gil; Naomi F Walker; Luísa Saraiva; Bernadette Pedersen; Francesco Mauri; Marc Lipman; Dylan R Edwards; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

10.  The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis.

Authors:  Basim Al Shammari; Takayuki Shiomi; Liku Tezera; Magdalena K Bielecka; Victoria Workman; Tarangini Sathyamoorthy; Francesco Mauri; Suwan N Jayasinghe; Brian D Robertson; Jeanine D'Armiento; Jon S Friedland; Paul T Elkington
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

View more
  18 in total

1.  Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.

Authors:  Paul T Elkington; Adrian C Bateman; Gareth J Thomas; Christian H Ottensmeier
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

Review 2.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

Review 3.  Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Authors:  Robert L Hunter
Journal:  Tuberculosis (Edinb)       Date:  2016-01-02       Impact factor: 3.131

4.  The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.

Authors:  Andrew D Graustein; David J Horne; Jerry J Fong; Flavio Schwarz; Heather C Mefford; Glenna J Peterson; Richard D Wells; Munyaradzi Musvosvi; Muki Shey; Willem A Hanekom; Mark Hatherill; Thomas J Scriba; Nguyen Thuy Thuong Thuong; Nguyen Thi Hoang Mai; Maxine Caws; Nguyen Duc Bang; Sarah J Dunstan; Guy E Thwaites; Ajit Varki; Takashi Angata; Thomas R Hawn
Journal:  Tuberculosis (Edinb)       Date:  2017-02-21       Impact factor: 3.131

5.  Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.

Authors:  Liku B Tezera; Salah Mansour; Paul Elkington
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

6.  Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection.

Authors:  Andrew Chancellor; Andrew White; Anna S Tocheva; Joe R Fenn; Mike Dennis; Liku Tezera; Akul Singhania; Tim Elliott; Marc Tebruegge; Paul Elkington; Stephan Gadola; Sally Sharpe; Salah Mansour
Journal:  Tuberculosis (Edinb)       Date:  2017-04-28       Impact factor: 3.131

Review 7.  Tuberculosis Infection and Latent Tuberculosis.

Authors:  Seung Heon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

8.  In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.

Authors:  Lucy C K Bell; Gabriele Pollara; Mellissa Pascoe; Gillian S Tomlinson; Rannakoe J Lehloenya; Jennifer Roe; Richard Meldau; Robert F Miller; Alan Ramsay; Benjamin M Chain; Keertan Dheda; Mahdad Noursadeghi
Journal:  PLoS Pathog       Date:  2016-03-17       Impact factor: 6.823

9.  Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology.

Authors:  Patience T Brace; Liku B Tezera; Magdalena K Bielecka; Toby Mellows; Diana Garay; Shuye Tian; Lucinda Rand; Justin Green; Sanjay Jogai; Andrew J Steele; Timothy M Millar; Tilman Sanchez-Elsner; Jon S Friedland; Christopher G Proud; Paul T Elkington
Journal:  PLoS Pathog       Date:  2017-06-01       Impact factor: 6.823

10.  Doxycycline host-directed therapy in human pulmonary tuberculosis.

Authors:  Qing Hao Miow; Andres F Vallejo; Yu Wang; Jia Mei Hong; Chen Bai; Felicia Sw Teo; Alvin Dy Wang; Hong Rong Loh; Tuan Zea Tan; Ying Ding; Hoi Wah She; Suay Hong Gan; Nicholas I Paton; Josephine Lum; Alicia Tay; Cynthia Be Chee; Paul A Tambyah; Marta E Polak; Yee Tang Wang; Amit Singhal; Paul T Elkington; Jon S Friedland; Catherine Wm Ong
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.